Thoratec Corp. (NSDQ:THOR) said the FDA sent it a letter warning about a pair of late filings with the federal watchdog agency, adding that resolving the issue shouldn’t affect its operations or finances.
The warning letter, which the heart pump maker said it received Jan. 4, flagged the late reports after inspections in August and September 2011 brought them to light, according to a regulatory filing.